Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 20 peer-reviewed journal articles Updated
General Surgery

Lipoma vs. Liposarcoma: Red Flags and Warning Signs

At a Glance

Most fatty lumps are benign lipomas, but a mass larger than 5 cm, deep, rapidly growing, firm, fixed, or recurrent needs prompt medical assessment. Imaging and specialized laboratory testing can help distinguish a lipoma from liposarcoma.

While the vast majority of fatty lumps are harmless lipomas, a small number may actually be a slow-growing type of cancer called liposarcoma. Specifically, doctors look for a condition called atypical lipomatous tumor (ALT)—also known as well-differentiated liposarcoma (WDL) [1].

It is important to understand that a benign lipoma does not “turn into” a liposarcoma [2]. Rather, a liposarcoma may be misdiagnosed as a lipoma in its early stages because they can look and feel very similar [2][3]. Recognizing the “red flags” that separate these two is essential for getting the right diagnosis.

The “Rule of Five” and Other Physical Red Flags

Doctors use a specific set of clinical features to decide if a fatty mass needs more intensive testing. These red flags include:

  • Size (>5 cm): Any fatty mass larger than 5 centimeters (roughly the size of a golf ball) is considered a warning sign that warrants prompt assessment [4][5]. While benign lipomas can routinely grow larger than this, most liposarcomas are already quite large by the time they are found [6][7].

Note: The 5-cm threshold is a referral and risk-assessment trigger, not a diagnosis of cancer and not an automatic indication for surgery.

  • Depth (Deep to Fascia): A lump that sits deep beneath the fascia (the tough layer of tissue covering your muscles) is more concerning than one that sits just under the skin [8][9].
  • Consistency and Mobility: A standard lipoma is usually soft and moves easily under the skin. A liposarcoma is often firm or hard and may feel fixed (stuck) to the structures beneath it [10][1]. However, these physical features modify concern but cannot completely distinguish the diagnoses: benign lipomas can occasionally feel firm, and concerning tumors can sometimes be deceptively mobile.
  • Rapid Growth: While both can grow slowly, a mass that shows a sudden or steady increase in size over a few months requires a prompt medical appointment [4].
  • Recurrence: If a lump was removed and has since grown back in the same spot, it raises the suspicion that the original diagnosis may need to be double-checked [11][12].

Why Location Matters

The location of the tumor can be a major clue. Liposarcomas are most frequently found in the proximal lower limb (the thigh and groin area) or deep inside the abdomen (the retroperitoneum) [11][1]. If you have a large, deep fatty mass in your thigh, doctors are much more likely to recommend specialized imaging than if you have a small, soft lump on your forearm [11].

ALT and WDL are essentially the same histologic entity. “Atypical lipomatous tumor” is commonly used for surgically amenable peripheral lesions (like those in the limbs), whereas “well-differentiated liposarcoma” is commonly used for deep central or retroperitoneal lesions where complete resection is more difficult. Both are locally recurrent tumors with little or no metastatic potential unless dedifferentiation occurs.

Advanced Testing: MRI and MDM2

If a mass has one or more red flags, your doctor will likely order an MRI. Radiologists look for specific “warning signs” on the scan, such as:

  • Thick septa: Walls within the tumor that are thicker than 2 millimeters [13][8].
  • Nodules: Solid, non-fatty lumps hiding inside the fatty mass [8][14].
  • Enhancement: Parts of the tumor that “light up” when contrast dye is used, signaling a high blood supply [13].

To definitively help tell the difference, a pathologist may perform a test for MDM2 amplification [15]. Atypical lipomatous tumors frequently have extra copies of the MDM2 gene, while benign lipomas do not [15][16]. This test is interpreted by a specialist pathologist alongside morphology, imaging, and anatomic site, rather than acting as a stand-alone result [17].

Seeking Specialist Care

If your lump has red flags, it is recommended that you be seen by a specialist sarcoma center [18]. General surgeons are experts at removing lipomas, but if there is any chance the mass is a liposarcoma, it requires a specialized surgical approach to ensure it is completely removed with clear margins [19][20]. Getting the right team involved early is the best way to ensure the lump is managed correctly the first time [18].

Common questions in this guide

Could a lipoma become liposarcoma over time?
No. A benign lipoma does not transform into a liposarcoma; they are separate conditions. A liposarcoma can resemble a lipoma early on, so a concerning or changing lump may have been mistaken for a lipoma and needs medical assessment.
Is a fatty lump over 5 cm automatically cancer?
No. A size over 5 cm is a referral and risk-assessment warning sign, not a diagnosis of cancer or an automatic reason for surgery. Benign lipomas can be larger, but a mass above this size should be assessed promptly.
What changes in a fatty lump should prompt a medical visit?
Concern increases when a mass is deep beneath the fascia, rapidly or steadily growing, firm, fixed, larger than 5 cm, or has returned after removal. These features do not prove liposarcoma, but they support prompt evaluation and possible referral to a sarcoma specialist.
What can an MRI show in a possible liposarcoma?
MRI can show whether a fatty mass is deep and whether it contains thick internal partitions, solid nodules, or areas that take up contrast dye. These findings can help doctors decide whether a biopsy or specialist evaluation is needed, but an MRI alone does not make the final diagnosis.
Why might my doctor order an MDM2 test?
Atypical lipomatous tumors, also called well-differentiated liposarcomas in some locations, often have extra copies of the MDM2 gene, whereas benign lipomas usually do not. A pathologist interprets the result together with the tissue appearance, imaging, and tumor location rather than using it by itself.
Why is a sarcoma center recommended for a concerning fatty lump?
A mass with concerning features should be evaluated through a specialist sarcoma center, where imaging, biopsy planning, pathology, and surgery can be coordinated. Specialized surgery is important if liposarcoma is possible because the goal is complete removal with clear margins.

Get notified when new evidence is published on lipoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (20)
  1. 1

    Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma with Intramuscular Lipoma-Like Component of the Thigh.

    Burusapat C, Wongprakob N, Wanichjaroen N, et al.

    Case reports in surgery 2020; (2020()):8846932 doi:10.1155/2020/8846932.

    PMID: 33414978
  2. 2

    Well-Differentiated Liposarcoma of the Posterior Neck: A Case Report.

    Almotairi N, Alghanem BY, Alotaibi M, AlMutairi MM

    Cureus 2024; (16(8)):e68179 doi:10.7759/cureus.68179.

    PMID: 39347341
  3. 3

    Successful Outcome in a Geriatric Patient With Giant Dedifferentiated Liposarcoma of the Lower Extremity: A Case Report.

    Martinez Martinez J, Munoz Munoz M, Pacheco Gonzalez CO

    Cureus 2025; (17(7)):e87800 doi:10.7759/cureus.87800.

    PMID: 40799866
  4. 4

    Diagnosis and treatment of soft-tissue sarcomas of the extremities and trunk.

    Smolle MA, Andreou D, Tunn PU, et al.

    EFORT open reviews 2017; (2(10)):421-431 doi:10.1302/2058-5241.2.170005.

    PMID: 29209518
  5. 5

    Soft tissue sarcoma in France in 2015: Epidemiology, classification and organization of clinical care.

    Honoré C, Méeus P, Stoeckle E, Bonvalot S

    Journal of visceral surgery 2015; (152(4)):223-30.

    PMID: 26088366
  6. 6

    Management of adipose tumors in the limbs.

    Le Nail LR, Crenn V, Rosset P, Ropars M

    Orthopaedics & traumatology, surgery & research : OTSR 2022; (108(1S)):103162 doi:10.1016/j.otsr.2021.103162.

    PMID: 34863958
  7. 7

    A scoring system combining clinical, radiological, and histopathological examinations for differential diagnosis between lipoma and atypical lipomatous tumor/well-differentiated liposarcoma.

    Asano Y, Miwa S, Yamamoto N, et al.

    Scientific reports 2022; (12(1)):237 doi:10.1038/s41598-021-04004-1.

    PMID: 34997060
  8. 8

    Diagnostic accuracy of CT and MR features for detecting atypical lipomatous tumors and malignant liposarcomas: a systematic review and meta-analysis.

    Wilson MP, Haidey J, Murad MH, et al.

    European radiology 2023; (33(12)):8605-8616 doi:10.1007/s00330-023-09916-2.

    PMID: 37439933
  9. 9

    Malignant Transformation and Progression of Musculoskeletal Lesions with Imaging-Pathology Correlation-Part 2: Soft Tissue Lesions.

    Jeong HS, Lee SK, Kim JY, et al.

    Diagnostics (Basel, Switzerland) 2026; (16(12)) doi:10.3390/diagnostics16121782.

    PMID: 42351442
  10. 10

    A Retrospective Study of Superficial Type Atypical Lipomatous Tumor.

    Mashima E, Sawada Y, Saito-Sasaki N, et al.

    Frontiers in medicine 2020; (7()):609515 doi:10.3389/fmed.2020.609515.

    PMID: 33392230
  11. 11

    Non-Radiographic Risk Factors Differentiating Atypical Lipomatous Tumors from Lipomas.

    Bird JE, Morse LJ, Feng L, et al.

    Frontiers in oncology 2016; (6()):197 doi:10.3389/fonc.2016.00197.

    PMID: 27713864
  12. 12

    MDM2 Amplification in Problematic Lipomatous Tumors: Analysis of FISH Testing Criteria.

    Clay MR, Martinez AP, Weiss SW, Edgar MA

    The American journal of surgical pathology 2015; (39(10)):1433-9 doi:10.1097/PAS.0000000000000468.

    PMID: 26146760
  13. 13

    Differentiating atypical lipomatous tumors from lipomas with magnetic resonance imaging: a comparison with MDM2 gene amplification status.

    Knebel C, Neumann J, Schwaiger BJ, et al.

    BMC cancer 2019; (19(1)):309 doi:10.1186/s12885-019-5524-5.

    PMID: 30943944
  14. 14

    Prognostic value of clinical and MRI features in the screening of lipomatous lesions.

    Scherrer Y, Laux CJ, Götschi T, et al.

    Surgical oncology 2023; (50()):101984 doi:10.1016/j.suronc.2023.101984.

    PMID: 37619507
  15. 15

    Prognostic Implications of MDM2 and CDK4 Co-amplification in Liposarcoma: Insights from FISH analysis for Translational Oncology.

    James J, Yajid AI, Yahaya S, et al.

    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2026; (28(1)):352-365 doi:10.1007/s12094-025-03989-9.

    PMID: 40665169
  16. 16

    MDM2 and CDK4 Immunohistochemistry: Should It Be Used in Problematic Differentiated Lipomatous Tumors?: A New Perspective.

    Clay MR, Martinez AP, Weiss SW, Edgar MA

    The American journal of surgical pathology 2016; (40(12)):1647-1652 doi:10.1097/PAS.0000000000000713.

    PMID: 27508976
  17. 17

    Criteria for MDM2 fluorescence in situ hybridization testing in the diagnosis of well-differentiated adipocytic neoplasms: a retrospective utilization review of 1151 cases.

    Flaman AN, Zhang L, Dickson BC, Demicco EG

    Virchows Archiv : an international journal of pathology 2025; (487(6)):1279-1289 doi:10.1007/s00428-025-04342-9.

    PMID: 41269286
  18. 18

    [Surgery of soft tissue sarcoma in adults].

    Bonvalot S, Tzanis D, Bouhadiba T, Meeus P

    La Revue du praticien 2025; (75(9)):964-968.

    PMID: 41575113
  19. 19

    UK guidelines for the management of soft tissue sarcomas.

    Dangoor A, Seddon B, Gerrand C, et al.

    Clinical sarcoma research 2016; (6()):20 doi:10.1186/s13569-016-0060-4.

    PMID: 27891213
  20. 20

    Pre-operative evaluation prior to soft tissue sarcoma excision - Why can't we get it right?

    Mesko NW, Wilson RJ, Lawrenz JM, et al.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2018; (44(2)):243-250 doi:10.1016/j.ejso.2017.11.001.

    PMID: 29269109

This page is for informational purposes only and does not replace medical advice or a diagnosis. A clinician, radiologist, and pathologist should evaluate any concerning lump, especially one that is large, deep, growing, firm, fixed, or recurrent.

Guide contents lipoma
Research & Literature
02 Symptoms, Variants, and Related Syndromes 04 Diagnosis, Imaging, and Pathology